Maria Grazia Roncarolo, MD
Maria Grazia is the George D. Smith Professor in Stem Cell and Regenerative Medicine, Professor of Pediatrics and of Medicine, founder of the Center for Definitive and Curative Medicine, and former co-director of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University. Dr. Roncarolo has spent her career translating discoveries in immune-mediated […]
David de Vries, MPhil
David has over a decade of experience founding and scaling companies at the intersection of healthcare and technology. Prior to Tr1X, David was Co-Founder and COO of Arine, a therapeutic optimization company he helped launch and scale to serve millions of patients across the US. Before that, he worked at Proteus Digital Health, one of […]
Bill Lis
Bill Lis has over 30 years of experience in the biopharmaceutical industry, at both the executive and board level. Bill currently serves as Executive Chairman and a member of the Board of Directors of Tr1X. Previously, he was Founding CEO and Executive Chairman at Jasper Therapeutics where he led the company’s Series A, public financing […]
Tao Fu, MBA
Mr. Fu is the Chief Executive Office and co-founder of Attovia Therapeutics, as well as a Venture Partner at Frazier Life Sciences. Mr. Fu is a seasoned industry leader with over 25 years of executive experience in the pharmaceutical and biotech industries, including leadership roles at Zai Lab, Portola Pharmaceuticals, Bristol-Myers Squibb and Johnson & […]
Leon Chen, PhD, MBA
Dr. Chen is a partner at The Column Group, currently serving on the board of directors of Eikon Therapeutics, Remix Therapeutics and Velia, in addition to Tr1X. Previously, he was a Venture Partner at OrbiMed focusing on company creation and investing in early-stage biotech companies. In this capacity he took on interim management roles at […]
Katherine High, MD
Dr. Kathy High is an accomplished hematologist with a longstanding interest in gene therapy for genetic disease. Most recently, Dr. High served as the President, Therapeutics of AskBio, a subsidiary of Bayer AG, and as a member of AskBio’s board of directors. Previously, Dr. High co-founded Spark Therapeutics, Inc. and from September 2014 to December […]